WEKO3
アイテム
Carbon Ion Radiotherapy for Skull Base and Paracervical Tumors
https://repo.qst.go.jp/records/62487
https://repo.qst.go.jp/records/624870b41727c-b878-4290-b25c-a68d1d122dad
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2008-03-26 | |||||
タイトル | ||||||
タイトル | Carbon Ion Radiotherapy for Skull Base and Paracervical Tumors | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Hasegawa, Azusa
× Hasegawa, Azusa× Mizoe, Junetsu× Takagi, Ryo× Bessho, Hiroki× Onda, Takeshi× Tsujii, Hirohiko× 長谷川 安都佐× 溝江 純悦× 高木 亮× 別所 央城× 恩田 健志× 辻井 博彦 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Purpose: To estimate the toxicity and efficacy of carbon ion radiotherapy for skull base and paracervical tumors. Materials and Methods: Between April 1997 and August 2007, a total of 46 patients with skull base or paracervical tumors have been treated with carbon ion radiotherapy for the phase I/II or phase II clinical trials. The 46 patients consisting of 20 males and 26 females, their age range was from 16 to 78, with a median age of 50 years. Histologically, 46 patients had 29 chordoma, 6 malignant meningioma, 7 chondrosarcoma, 3 olfactory neuroblastoma and one giant cell sarcoma. Results: Median follow-up time in 46 patients was 50 months (range, 4-122 months). At the time of analysis, there was no evidence of any serious acute or late reactions. The five-year local control rates according to prescribed tumor dose were 75% at 48 GyE (n=4), 67% at 52.8 GyE (n=6), 78% at 57.6 GyE (n=9) and 93% at 60.8 GE (n=27), respectively. The five-year overall survival rates were 50% at 48 GyE, 100% at 52.8 GyE, 100% at 57.6 GyE and 76% at 60.8 GyE, respectively. In 29 chordoma patients, they were divided into two groups; a low-dose group (n=10) irradiated with doses ranging from 48 to 57.8 GyE and a high-dose group (n=19) irradiated with a 60.8 GyE. The five-year local control rates were 60% for the low-dose group and 91% for the high-dose group. The five-year overall survival rates were 89% for the low-dose group and 94% for the high-dose group. Conclusions: Carbon ion radiotherapy will deliver a high local control rates with low toxicity to the surrounding normal tissues. |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | NIRS-MD Anderson Symposium on Clinical lssues for Particle Therapy | |||||
発表年月日 | ||||||
日付 | 2008-03-22 | |||||
日付タイプ | Issued |